Clinical Kidney Journal · Oct 15, 2026
Lipid control in a cohort of patients with cardiorenal disease (LIPID-REN): a subanalysis of the CARDIOREN registry
By Garrido-González R, Castro A, de la Espriella R et al.
AIMS: Advanced chronic kidney disease (CKD) confers a very high cardiovascular disease (CVD) risk, requiring comprehensive risk factor assessment. However, real-world data on current practices in patients with cardiorenal disease remain limited. We aimed to evaluate the control of cardiovascular risk factors, with a focus on lipid management, in a contemporary cardiorenal cohort. METHODS: This cross-sectional analysis was conducted within the CARDIOREN Registry, which enrolled patients with chronic heart failure from 13 tertiary hospitals in Spain (2021-2022). Of 1107 patients, 885 with complete data on low-density lipoprotein cholesterol (LDL-C), albuminuria, and atherosclerotic CVD (ASCVD) were eligible. The present analysis was restricted to the patients who met the definition of advanced CKD, defined as estimated glomerular filtration rate (eGFR) <30 ml/min/1.73 m² or eGFR 30-45 ml/min/1.73 m² with albuminuria >30 mg/g. ASCVD was defined as prior ischemic heart disease, stroke, or peripheral arterial disease. The proportion of patients with LDL-C <55 mg/dl was assessed. Multivariable logistic regression models, including a parsimonious primary model and sensitivity analyses, were used to identify factors associated with lower LDL-C levels. RESULTS: Advanced CKD was present in 221 patients (25%); median age was 79 years, 58.8% were male, and 52.9% had ASCVD. Median LDL-C was 73 mg/dl, and only 22.6% achieved an LDL-C <55 mg/dl. Achievement of LDL-C <55 mg/dl was significantly lower in patients without ASCVD compared with those with ASCVD (13.4% vs. 30.7%; P = .002). In multivariable analysis, ASCVD was independently associated with a higher likelihood of achieving LDL-C <55 mg/dl, whereas female sex was independently associated with a lower likelihood of achieving this level. CONCLUSIONS: In patients with advanced CKD, lipid control was below cardiology guideline recommendations for patients at very high CVD risk, particularly among those without ASCVD and in women.
doi.org/10.1093/ckj/sfag369Open accessPubMed 43011269Populations